Johnson & Johnson Stock News

Global Ocular Surgery Market, by Procedure Type (Cataract Surgery, Glaucoma Surgery, and Vitrectomy Surgery), by Device Type (Cataract Surgery Devices (IOL (Intraocular Lenses), OVD (Ophthalmic Viscosurgical Devices) and Phacoemulsification Devices), Glaucoma Surgery Devices (GDD (Glaucoma Drainage Device), Implants and Stents

- New investors include US life science investors HealthQuest Capital, Casdin Capital, and American Cancer Society BrightEdge, and Asia -based global healthcare investors Tybourne Capital Management and NSG Ventures - Following the most recent strategic investment of $26 million from Guardant Health, the company has now secured more than $135 million in total ahead of its planned KOSDAQ IPO next year SEOUL, South Korea , Nov. 25, 2021 /PRNewswire/ -- Lunit, a leading medical AI provider, today announced it has raised $61 million in its Pre-IPO fundraising round ahead of the company''s planned public offering on the South Korean stock market (KOSDAQ) early next year. A number of new investors have joined the round including leading US healthcare investors HealthQuest Capital, Casdin Capital, and American Cancer Society BrightEdge, as well as Asia -based global healthcare investors Tybourne Capital Management, and NSG Ventures. HealthQuest Capital invested $20 million of the total funding amount.

Global Rapid-acting Diabetes Market 2021-2027 The latest research study on Global Rapid-acting Diabetes Market offers a detailed overview of the factors influencing the global business scope. Rapid-acting Diabetes Market research report shows the latest market insights, current situation analysis with upcoming

A Global Orthopaedic Surgical Robots Market, which is an in-depth study providing complete analysis of the industry for the period 2021 to 2027. It provides complete overview of Global Orthopaedic Surgical Robots industry considering all the major industry trends, market

The "Innovative Drug" Market report offers qualitative and quantitative insights and a detailed analysis of market size & growth rate for all possible segments in the market. The Global Innovative Drug Industry presents a market overview, product details, classification, and

Health Canada has authorized the single-shot COVID-19 vaccine of Janssen, a Johnson & Johnson (JNJ) company, to prevent COVID-19 in individuals aged 18 years and older. The post Health Canada Approves Johnson & Johnsons COVID-19 Vaccine appeared first on Smarter Analyst .

Centennial Resource Development, Inc. (CDEV) with the stream of 0.98% also noticed, India Johnson & Johnson (JNJ) encountered a rapid change of -0.26% in the last hour of Wednesdays trading The post Active Stocks Momentum: Centennial Resource Development, Inc. (NASDAQ:CDEV), Johnson & Johnson (NYSE:JNJ) appeared first on Stocks Equity .

The full authorization makes Canada the first country to do so for Johnson & Johnson''s COVID vaccine.

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH boosted its holdings in shares of Johnson & Johnson (NYSE:JNJ) by 44.3% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 119,788 shares of the companys stock after purchasing an additional 36,792 shares during the period. Johnson & Johnson accounts for approximately 3.4% of MEAG MUNICH ERGO Kapitalanlagegesellschaft mbHs portfolio, []

The one-dose COVID-19 vaccine produced by Johnson & Johnson has received full authorization in Canada, which is the first country to give the shot full approval, the company said Wednesday.

Buffington Mohr McNeal increased its position in Johnson & Johnson (NYSE:JNJ) by 2.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 15,483 shares of the company’s stock after buying an additional 361 shares during the quarter. Buffington Mohr McNeal’s holdings in Johnson & Johnson […]

Jacobs & Co. CA increased its holdings in shares of Johnson & Johnson (NYSE:JNJ) by 0.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,672 shares of the company’s stock after acquiring an additional 125 shares during the period. Jacobs […]

Canada has become the first country to fully approve Johnson & Johnson''s (NYSE: JNJ ) single-dose Covid-19 vaccine. According to a statement, regulators based their decision on the Phase 3 ENSEMBLE study, which showed an 85% efficacy against severe disease. The move comes after Health Canada granted full approval to the Pfizer Inc (NYSE: PFE ) Full story available on Benzinga.com

The U.S. Embassy welcomed the arrival of 1.3 million doses of Johnson & Johnson vaccine to Cairo on November 24th. This shipment of an additional 1.3 million doses, part of 9.6 million doses of Johnson & Johnson and Pfizer vaccines donated from the United States to Egypt through COVAX, will help protect Egyptians from Coronavirus []